Literature DB >> 31838607

Physician perceptions of a multidisciplinary endocarditis team.

Sami El-Dalati1,2, Irina Khurana3, Nathaniel Soper3, Daniel Cronin4, Michael Shea5, Richard L Weinberg5, James Riddell6, Laraine Washer6, Emily Shuman6, James Burke7, Sadhana Murali7, D Alexander Perry6, Christopher Fagan3, Twisha Patel8, Kirra Ressler9, George Michael Deeb9.   

Abstract

Infectious endocarditis is a highly morbid infection that requires coordination of care across medical and surgical specialties, often through the use of a multidisciplinary team model. Multiple studies have demonstrated that such conferences can improve clinical outcomes. However, little is known about physicians' impressions of these groups. We surveyed 126 (response rate of 30%) internal medicine, infectious diseases, cardiology, and cardiac surgery providers 1 year after the implementation of an endocarditis team at the University of Michigan. Ninety-eight percent of physicians felt that the endocarditis team improved communication between specialties. Additionally, over 85% of respondents agreed that the group influenced diagnostic evaluation, reduced management errors, increased access to surgery, and decreased in-hospital mortality for endocarditis patients. These results suggest that multidisciplinary endocarditis teams are valued by physicians as a tool to improve patient care and serve an important role in increasing communication between providers.

Entities:  

Keywords:  Endocarditis; Interdisciplinary; Multidisciplinary care; Surveys; Valvular heart disease

Year:  2019        PMID: 31838607     DOI: 10.1007/s10096-019-03776-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Dramatic reduction in infective endocarditis-related mortality with a management-based approach.

Authors:  Elisabeth Botelho-Nevers; Franck Thuny; Jean Paul Casalta; Hervé Richet; Frédérique Gouriet; Frédéric Collart; Alberto Riberi; Gilbert Habib; Didier Raoult
Journal:  Arch Intern Med       Date:  2009-07-27

Review 2.  Overconfidence as a cause of diagnostic error in medicine.

Authors:  Eta S Berner; Mark L Graber
Journal:  Am J Med       Date:  2008-05       Impact factor: 4.965

Review 3.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

4.  Influence of a multidisciplinary alert strategy on mortality due to left-sided infective endocarditis.

Authors:  Fernando Carrasco-Chinchilla; Gemma Sánchez-Espín; Josefa Ruiz-Morales; Isabel Rodríguez-Bailón; Jose M Melero-Tejedor; Rada Ivanova-Georgieva; Victoria García-López; Antonio Muñoz-García; Juan J Gómez-Doblas; Eduardo de Teresa-Galván
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2014-01-17

5.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

6.  Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis.

Authors:  Elana S Rosenthal; Adolf W Karchmer; Jesse Theisen-Toupal; Roger Araujo Castillo; Chris F Rowley
Journal:  Am J Med       Date:  2015-11-18       Impact factor: 4.965

Review 7.  Communication in healthcare: a narrative review of the literature and practical recommendations.

Authors:  P Vermeir; D Vandijck; S Degroote; R Peleman; R Verhaeghe; E Mortier; G Hallaert; S Van Daele; W Buylaert; D Vogelaers
Journal:  Int J Clin Pract       Date:  2015-07-06       Impact factor: 2.503

8.  Infective endocarditis in the U.S., 1998-2009: a nationwide study.

Authors:  David H Bor; Steffie Woolhandler; Rachel Nardin; John Brusch; David U Himmelstein
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  8 in total
  4 in total

1.  Surgeons' Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis.

Authors:  Alysse G Wurcel; Julia Zubiago; Jessica Reyes; Emma Smyth; Keki R Balsara; Danielle Avila; Joshua A Barocas; Curt G Beckwith; Jenny Bui; Cody A Chastain; Ellen F Eaton; Simeon Kimmel; Molly L Paras; Asher J Schranz; Darshali A Vyas; Alison Rapoport
Journal:  Ann Thorac Surg       Date:  2022-01-31       Impact factor: 5.102

2.  The Impact of Multidisciplinary Conferences on Healthcare Utilization in Chronic Pain Patients.

Authors:  Zahabiya Campwala; Gregory Davis; Olga Khazen; Rachel Trowbridge; Melisande Nabage; Rohan Bagchi; Charles Argoff; Julie G Pilitsis
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-22

3.  Poor long-term outcomes of intravenous drug users with infectious endocarditis.

Authors:  Juan Caceres; Aroosa Malik; Tom Ren; Aroma Naeem; Jeffrey Clemence; Alexander Makkinejad; Xiaoting Wu; Bo Yang
Journal:  JTCVS Open       Date:  2022-05-31

Review 4.  A step-by-step guide to implementing a multidisciplinary endocarditis team.

Authors:  Sami El-Dalati; Daniel Cronin; James Riddell; Michael Shea; Richard L Weinberg; Emily Stoneman; Twisha Patel; Kirra Ressler; George Michael Deeb
Journal:  Ther Adv Infect Dis       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.